Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
TNGX | Tango Therapeutics, Inc. | Chief Executive Officer, Director | $19.4M | -$115K | -0.59% | Feb 6, 2024 |
RVMD, RVMDW | Revolution Medicines, Inc. | Director | $627K | -$250K | -28.5% | Oct 8, 2024 |
OHAA | Opy Acquisition Corp. I | Director | Oct 26, 2021 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|